5-Azacitidine has limited therapeutic activity in myelofibrosis.
Mesa
R A
RA
Verstovsek
S
S
Rivera
C
C
Pardanani
A
A
Hussein
K
K
Lasho
T
T
Wu
W
W
Tefferi
A
A
D000368:Aged; D001374:Azacitidine / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D055728:Primary Myelofibrosis / Q000188:drug therapy*; D017211:Treatment Failure; D016896:Treatment Outcome
D001374:Azacitidine